JNJ logo

JOHNSON & JOHNSON

JNJNYSE
πŸ† #21 by market capEarnings Jan 20 Β· PreUS Equity
β€”β€”
Quote unavailable
πŸ””
Track JNJ
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$651.11B
Large Cap
πŸ“ˆRevenue Growth (YoY)
7.8%
Slowing
πŸ“ŠGross Margin
67.7%
High
πŸ’΅FCF Margin
20.7%
Strong
βš–οΈP/S Ratio
6.6x
Fair
Otter Score
72
Strong
No chart data available for JNJ.

Trading Snapshot

Day Range
β€”
52-Week Range
$199.38 – $290.25
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
2.41B
Next Earnings
2027-01-20

Fundamentals Snapshot

Annual Revenue
$94.19B
Last Q Revenue
$25.40B
P/E Ratio
40.7
P/S Ratio
6.6x
EPS (TTM)
$6.59
Dividend Yield
1.94%
Dilution (1yr)
+0.5%
JNJ logo

JOHNSON & JOHNSON

JNJ
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$94.2Bβ–² +6.0% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
67.9%β–Ό βˆ’1.7% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$25.6Bβ–² +15.6% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$19.7Bβ–Ό βˆ’0.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
2.44Bβ–² +0.5% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$28.2Bβ–Ό βˆ’$15.7B YoY
StockOtter Β· stockotter.space

About JOHNSON & JOHNSON

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Strong
72/100
Analyst data unavailable.

Latest News & Updates

News unavailable.